CAS 563-83-7|Isobutyramide
Introduction：Basic information about CAS 563-83-7|Isobutyramide, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | Isobutyramide | ||
|---|---|---|---|
| CAS Number | 563-83-7 | Molecular Weight | 87.120 |
| Density | 0.9±0.1 g/cm3 | Boiling Point | 221.4±8.0 °C at 760 mmHg |
| Molecular Formula | C4H9NO | Melting Point | 127-131 °C(lit.) |
| MSDS | ChineseUSA | Flash Point | 87.7±18.4 °C |
| Symbol | GHS07 | Signal Word | Warning |
Names
| Name | Isobutyramide |
|---|---|
| Synonym | More Synonyms |
Chemical & Physical Properties
| Density | 0.9±0.1 g/cm3 |
|---|---|
| Boiling Point | 221.4±8.0 °C at 760 mmHg |
| Melting Point | 127-131 °C(lit.) |
| Molecular Formula | C4H9NO |
| Molecular Weight | 87.120 |
| Flash Point | 87.7±18.4 °C |
| Exact Mass | 87.068413 |
| PSA | 43.09000 |
| LogP | -0.36 |
| Vapour Pressure | 0.1±0.4 mmHg at 25°C |
| Index of Refraction | 1.418 |
| InChIKey | WFKAJVHLWXSISD-UHFFFAOYSA-N |
| SMILES | CC(C)C(N)=O |
Toxicological Information
CHEMICAL IDENTIFICATION |
ACUTE TOXICITY DATA - TYPE OF TEST :
- LD50 - Lethal dose, 50 percent kill
- ROUTE OF EXPOSURE :
- Intravenous
- SPECIES OBSERVED :
- Mammal - species unspecified
- DOSE/DURATION :
- 3 gm/kg
- TOXIC EFFECTS :
- Details of toxic effects not reported other than lethal dose value
- REFERENCE :
- USXXAM United States Patent Document. (U.S. Patent Office, Box 9, Washington, DC 20231) Volume(issue)/page/year: #5439939
Safety Information
| Symbol | GHS07 |
|---|---|
| Signal Word | Warning |
| Hazard Statements | H302 |
| Hazard Codes | Xn |
| Risk Phrases | 22 |
| Safety Phrases | S24/25 |
| RIDADR | NONH for all modes of transport |
| WGK Germany | 3 |
| RTECS | TX1475000 |
| HS Code | 2924199090 |
Customs
| HS Code | 2924199090 |
|---|---|
| Summary | 2924199090. other acyclic amides (including acyclic carbamates) and their derivatives; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0% |
Articles26
More Articles| A New Signaling Pathway for HCV Inhibition by Estrogen: GPR30 Activation Leads to Cleavage of Occludin by MMP-9. PLoS ONE 11 , e0145212, (2016) Poor outcome in response to hepatitis C virus, including higher viral load, hepatocellular carcinoma and cirrhosis, is more associated with men and postmenopausal women than with premenopausal women a... | |
| Induction of fetal hemoglobin expression by the histone deacetylase inhibitor apicidin. Blood 101(5) , 2001-7, (2003) Pharmacologic stimulation of fetal hemoglobin (HbF) expression may be a promising approach for the treatment of beta-thalassemia. In this study, we have investigated the HbF-inducing activity and mole... | |
| Effects of ketoacidosis on rat apolipoprotein A1 gene expression: a link with acidosis but not with ketones. J. Mol. Endocrinol. 25(1) , 129-39, (2000) To determine if ketoacidosis contributes to reduced apolipoprotein A1 (apoA1) expression in insulin-deficient diabetic rats, we examined the regulation of apoA1 gene expression in response to changes ... |
Synonyms
| 2-methylpropaneamide |
| EINECS 209-265-9 |
| Propanamide, 2-methyl- |
| isopropylformamide |
| IBA |
| iso-Butyleneamine |
| isobutyrimidicacid |
| Isobutyramide |
| isobutyric amide |
| MFCD00008019 |
| Isobuytramide |
| 2-Methylpropanamide |
| anhydrous dimethyl-acetamide |
| Methyl propionic acid amide |
| VX 366 |
| 2-methylpropionamide |
